Copyright
©The Author(s) 2025.
World J Psychiatry. Dec 19, 2025; 15(12): 109680
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.109680
Published online Dec 19, 2025. doi: 10.5498/wjp.v15.i12.109680
Figure 1 Cohort selection flowchart for the risk of neurological and psychiatric diagnoses following coronavirus disease 2019 infection.
COVID-19: Coronavirus disease 2019.
Figure 2 Comparative analysis of baseline characteristics and major outcomes between the coronavirus disease 2019 and other cohorts.
A: Baseline characteristics for the coronavirus disease 2019 (COVID-19) cohort and control cohort; B: Major outcomes for the whole COVID-19 cohort, and for the non-COVID-19 control cohort. COVID-19: Coronavirus disease 2019.
Figure 3 Risk of neurological and psychiatric outcomes in coronavirus disease 2019 patients (adjusted for confounders).
A: Nerve plexus disease; B: Anxiety disorder; C: Myoneural junction; D: Mood disorder; E: Ischemic stroke; F: Insomnia; G: Cognitive deficit; H: Psychotic disorder; I: Parkinsonism; J: Substance use disorder; K: Intracranial hemorrhage; L: Epilepsy; M: Dementia; N: Encephalic.
Figure 4 Odds ratio for risk of neurological and psychiatric disorders among coronavirus disease 2019 patients.
COVID-19: Coronavirus disease 2019.
- Citation: Ramadan M, Malaka L, Ghabrah R, Sulimani A, Aljadani F, Al Dosari L, Alsiary R. Risk of neurological and psychiatric diagnoses in COVID-19 survivors: A multicenter retrospective cohort study using electronic health records. World J Psychiatry 2025; 15(12): 109680
- URL: https://www.wjgnet.com/2220-3206/full/v15/i12/109680.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i12.109680